Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-12-19
DOI
10.1002/med.21548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulation of Mcl-1 inhibits JQ1-triggered anticancer activity in hepatocellular carcinoma cells
- (2018) Hua-Peng Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth
- (2018) Max A. Cheng et al. CANCER LETTERS
- Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
- (2018) Mahalakshmi Ramadoss et al. DRUG DISCOVERY TODAY
- Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
- (2018) Jun Luo et al. EUROPEAN UROLOGY
- Apalutamide: the established and emerging roles in the treatment of advanced prostate cancer
- (2018) Athanasios E. Dellis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Abiraterone acetate and its use in the treatment of metastatic prostate cancer: a review
- (2018) Orazio Caffo et al. Future Oncology
- The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
- (2018) Saghar Yousefnia et al. GENE
- The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer
- (2018) Andrew J. Wilson et al. GYNECOLOGIC ONCOLOGY
- Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
- (2018) Hong Zhang et al. HEPATOLOGY
- A plurality of molecular targets: The receptor ecosystem for bisphenol-A (BPA)
- (2018) Harry MacKay et al. HORMONES AND BEHAVIOR
- Niclosamide in combination with abiraterone and prednisone in men with castration-resistant prostate cancer (CRPC): initial results from a phase Ib/II trial.
- (2018) Chong-xian Pan et al. JOURNAL OF CLINICAL ONCOLOGY
- A systematic review of metabolomics biomarkers for Bisphenol A exposure
- (2018) Mu Wang et al. Metabolomics
- Development of selective androgen receptor modulators (SARMs)
- (2018) Ramesh Narayanan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
- (2018) Eugenio Zoni et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Bromodomain-containing proteins in prostate cancer
- (2018) Alfonso Urbanucci et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Tissue control of androgen action: The ups and downs of androgen receptor expression
- (2018) Irene Hunter et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
- (2018) Guillaume P. Andrieu et al. MOLECULAR CANCER RESEARCH
- Cheminformatics Driven Development of Novel Therapies for Drug Resistant Prostate Cancer
- (2018) Fuqiang Ban et al. Molecular Informatics
- Clinical implications of PTEN loss in prostate cancer
- (2018) Tamara Jamaspishvili et al. Nature Reviews Urology
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma
- (2018) A. Esteve-Arenys et al. ONCOGENE
- A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
- (2018) Michael T. Schweizer et al. PLoS One
- Assessing ecotoxicity and the endocrine potential of selected phthalates, BADGE and BFDGE derivatives in relation to environmentally detectable levels
- (2018) Natalia Szczepańska et al. SCIENCE OF THE TOTAL ENVIRONMENT
- The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells
- (2018) Marie C. Hupe et al. WORLD JOURNAL OF UROLOGY
- Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer
- (2018) Qiuping Xiang et al. ACS Medicinal Chemistry Letters
- Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer
- (2018) Aishwarya Pawar et al. Cell Reports
- Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
- (2018) Loredana Puca et al. Cold Spring Harbor Perspectives in Medicine
- Androgen receptor suppresses prostate cancer cell invasion via altering the miR-4496/β-catenin signals
- (2018) Rui-feng Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
- (2018) Kush Dalal et al. CANCER LETTERS
- Fighting tubulin-targeting anticancer drug toxicity and resistance
- (2017) Roberta Visconti et al. ENDOCRINE-RELATED CANCER
- BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations
- (2017) Mark C. Markowski et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer
- (2017) Étienne Audet-Walsh et al. GENES & DEVELOPMENT
- Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
- (2017) Bin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
- (2017) Kush Dalal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mechanics of microtubule networks in cell division
- (2017) Scott Forth et al. JOURNAL OF CELL BIOLOGY
- The novel role of pyrvinium in cancer therapy
- (2017) Amir A. Momtazi-borojeni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Correction to Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
- (2017) Huifang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
- (2017) Norihito Shibata et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
- (2017) Kwok-Ho Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug Discovery Targeting Bromodomain-Containing Protein 4
- (2017) Zhiqing Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
- (2017) Ian Churcher JOURNAL OF MEDICINAL CHEMISTRY
- Bromodomain Histone Readers and Cancer
- (2017) Abhinav K Jain et al. JOURNAL OF MOLECULAR BIOLOGY
- C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer
- (2017) Anca Azoitei et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
- (2017) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions
- (2017) Kush Dalal et al. MOLECULAR CANCER THERAPEUTICS
- Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
- (2017) Michael A. Gordon et al. MOLECULAR CANCER THERAPEUTICS
- Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer
- (2017) Deepak Babu et al. NATURE GENETICS
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- (2017) Xiangpeng Dai et al. NATURE MEDICINE
- Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
- (2017) Pingzhao Zhang et al. NATURE MEDICINE
- Structural basis of DNA duplex distortion induced by thiazole-containing hairpin polyamides
- (2017) Giacomo Padroni et al. NUCLEIC ACIDS RESEARCH
- Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
- (2017) W-Y Chen et al. ONCOGENE
- Poly(ADP-ribose) polymerase activity and inhibition in cancer
- (2017) Caleb Dulaney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Inhibitoren des Androgenrezeptor-N-Terminus’
- (2017) M. C. Hupe et al. UROLOGE
- Inhibitoren des Androgenrezeptor-N-Terminus’
- (2017) M. C. Hupe et al. UROLOGE
- Structure of the homodimeric androgen receptor ligand-binding domain
- (2017) Marta Nadal et al. Nature Communications
- Vitamin K epoxide reductase regulation of androgen receptor activity
- (2017) Ben Yi Tew et al. Oncotarget
- Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
- (2017) Cristiana Pistol Tanase et al. Oncotarget
- Androgen receptor splice variants and prostate cancer: From bench to bedside
- (2017) Kristine M. Wadosky et al. Oncotarget
- Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
- (2017) Alfonso Urbanucci et al. Cell Reports
- Small molecules remain on target for c-Myc
- (2017) Linchong Sun et al. eLife
- A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
- (2017) Hubert Pakula et al. Cancers
- The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
- (2017) Kurtis Eisermann et al. Cancers
- EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor
- (2016) Eva De Mol et al. ACS Chemical Biology
- The salicylanilide derivatives inhibit signal transducer and activator of transcription 3 pathways in A549 lung cancer cells
- (2016) Minhua Hu et al. ANTI-CANCER DRUGS
- Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
- (2016) Shunyan Weng et al. BMC GASTROENTEROLOGY
- Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer
- (2016) Ka-wing Fong et al. CANCER RESEARCH
- Role of taxanes in advanced prostate cancer
- (2016) J. Cassinello et al. Clinical & Translational Oncology
- Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer
- (2016) Y. C. Yang et al. CLINICAL CANCER RESEARCH
- Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia
- (2016) Bei Jin et al. CLINICAL CANCER RESEARCH
- Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
- (2016) K. Satoh et al. CLINICAL CANCER RESEARCH
- Clinical progress and pharmacology of small molecule bromodomain inhibitors
- (2016) Natalie H Theodoulou et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
- (2016) Kamlesh Yadav et al. CURRENT PHARMACEUTICAL DESIGN
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- Emerging data on androgen receptor splice variants in prostate cancer
- (2016) Subing Cao et al. ENDOCRINE-RELATED CANCER
- Bromodomain inhibitors and cancer therapy: From structures to applications
- (2016) Montserrat Pérez-Salvia et al. Epigenetics
- Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer
- (2016) Junjun Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family
- (2016) Mohammed A. Suliman et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
- (2016) Yasushi Taniguchi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
- (2016) Yusuke Imamura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
- (2016) Carmen A. Banuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells
- (2016) Emuejevoke Olokpa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
- (2016) Malte B. Monin et al. JOURNAL OF SURGICAL RESEARCH
- Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation
- (2016) Nada Lallous et al. MOLECULAR CANCER THERAPEUTICS
- Bromodomains: Translating the words of lysine acetylation into myelin injury and repair
- (2016) Achilles Ntranos et al. NEUROSCIENCE LETTERS
- Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
- (2016) E. S. Antonarakis et al. ONCOLOGIST
- Sleeping Beautyscreen revealsPpargactivation in metastatic prostate cancer
- (2016) Imran Ahmad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
- (2016) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer
- (2016) Junjun Liu et al. TUMOR BIOLOGY
- Galeterone for the treatment of advanced prostate cancer: the evidence to date
- (2016) Emmanuel Antonarakis et al. Drug Design Development and Therapy
- Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
- (2016) Chi-Kang Lin et al. Oncotarget
- Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
- (2016) Chengfei Liu et al. Oncotarget
- A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion
- (2016) Magdalena L. Circu et al. PLoS One
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes
- (2015) D. Xu et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer
- (2015) M. Kato et al. CLINICAL CANCER RESEARCH
- Global Assessment of Bisphenol A in the Environment
- (2015) Jone Corrales et al. Dose-Response
- High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models
- (2015) Rute B. Marques et al. EUROPEAN UROLOGY
- Persistent androgen receptor addiction in castration-resistant prostate cancer
- (2015) Michael T. Schweizer et al. Journal of Hematology & Oncology
- Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
- (2015) Hyung Kyu Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
- (2015) Vincent C. O. Njar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
- (2015) Siu Chiu Chan et al. NUCLEIC ACIDS RESEARCH
- Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest
- (2015) ZONGHUAN LI et al. ONCOLOGY REPORTS
- Total Synthesis of 7-Hydroxymurrayazolinine, Murrayamine D, and Mahanine via m-Nitro Group Activated Pyran Annulation
- (2015) Shujie Hou et al. ORGANIC LETTERS
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression
- (2015) MINORU TOMIZAWA et al. Oncology Letters
- Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
- (2015) Guanyi Zhang et al. Oncotarget
- EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer
- (2015) Lucas J. Brand et al. Oncotarget
- BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
- (2015) Emma K Baker et al. Scientific Reports
- Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
- (2015) Diane Ojo et al. Cancers
- Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
- (2015) Anastasia Wyce et al. Oncotarget
- Androgen receptor: structure, role in prostate cancer and drug discovery
- (2014) MH Eileen Tan et al. ACTA PHARMACOLOGICA SINICA
- A C-14 labeled Py–Im polyamide localizes to a subcutaneous prostate cancer tumor
- (2014) Jevgenij A. Raskatov et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
- (2014) Yonghe Li et al. CANCER LETTERS
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors
- (2014) Steven G. Smith et al. CHEMISTRY & BIOLOGY
- Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor
- (2014) Z. Yu et al. CLINICAL CANCER RESEARCH
- Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2014) C. Liu et al. CLINICAL CANCER RESEARCH
- Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
- (2014) Kush Dalal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor Xenograft Uptake of a Pyrrole–Imidazole (Py-Im) Polyamide Varies as a Function of Cell Line Grafted
- (2014) Jevgenij A. Raskatov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
- (2014) Huifang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Niclosamide on Basal-like Breast Cancers
- (2014) A. I. Londono-Joshi et al. MOLECULAR CANCER THERAPEUTICS
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
- (2014) Sarah K. Martin et al. Molecular Oncology
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
- (2014) M L King et al. ONCOGENE
- Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
- (2014) R Ferraldeschi et al. ONCOGENE
- Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
- (2014) Carmen A. Banuelos et al. PLoS One
- Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium
- (2013) Minyoung Lim et al. ACS Chemical Biology
- Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
- (2013) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
- (2013) A. Schroeder et al. CANCER RESEARCH
- PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
- (2013) S. Picaud et al. CANCER RESEARCH
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Bisphenol A affects androgen receptor function via multiple mechanisms
- (2013) Christina Teng et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Anticancer Effects of Niclosamide in Human Glioblastoma
- (2013) A. Wieland et al. CLINICAL CANCER RESEARCH
- Castration-resistant Prostate Cancer: Where We Stand in 2013 and What Urologists Should Know
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer
- (2013) John M. Fitzpatrick et al. EUROPEAN UROLOGY
- Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
- (2013) Nada Lallous et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis
- (2013) Tzu-Hua Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An androgen receptor N-terminal domain antagonist for treating prostate cancer
- (2013) Jae-Kyung Myung et al. JOURNAL OF CLINICAL INVESTIGATION
- Animal Toxicity of Hairpin Pyrrole-Imidazole Polyamides Varies with the Turn Unit
- (2013) Fei Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Naturally Derived Small Molecule Disrupts Ligand-Dependent and Ligand-Independent Androgen Receptor Signaling in Human Prostate Cancer Cells
- (2013) K. S. Amin et al. MOLECULAR CANCER THERAPEUTICS
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
- (2013) R. Li et al. MOLECULAR CANCER THERAPEUTICS
- The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
- (2013) Scott R. Floyd et al. NATURE
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
- (2013) Lina Gao et al. PLoS One
- Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
- (2013) Yu-Chi Wang et al. PLoS One
- Antitumor activity of a pyrrole-imidazole polyamide
- (2013) F. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- Small-Molecule Inhibition of BRDT for Male Contraception
- (2012) Martin M. Matzuk et al. CELL
- The androgen receptor gene mutations database: 2012 update
- (2012) Bruce Gottlieb et al. HUMAN MUTATION
- Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinomain vitroandin vivo
- (2012) Sayantani Sarkar et al. INTERNATIONAL JOURNAL OF CANCER
- Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
- (2012) Siu Chiu Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation
- (2012) Shaoyong Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stepwise androgen receptor dimerization
- (2012) M. E. van Royen et al. JOURNAL OF CELL SCIENCE
- Characterization and Solubilization of Pyrrole–Imidazole Polyamide Aggregates
- (2012) Amanda E. Hargrove et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
- (2012) Paul V. Fish et al. JOURNAL OF MEDICINAL CHEMISTRY
- Growth Inhibition of Ovarian Tumor-Initiating Cells by Niclosamide
- (2012) Y.-T. Yo et al. MOLECULAR CANCER THERAPEUTICS
- The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity
- (2012) Colin W. Hay et al. PLoS One
- Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
- (2012) Jing-Xuan Pan et al. Chinese Journal of Cancer
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity: Figure 1.
- (2011) Marianne D. Sadar CANCER RESEARCH
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
- (2011) M. S. Darshan et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity
- (2011) Labros G. Meimetis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Disruption of androgen receptor signaling in males by environmental chemicals
- (2011) Doug C. Luccio-Camelo et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
- (2011) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
- (2011) Wenyan Lu et al. PLoS One
- Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure
- (2011) Alfonso Urbanucci et al. PROSTATE
- Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
- (2011) F L Khanim et al. Blood Cancer Journal
- Transcription Factor Stat3 Stimulates Metastatic Behavior of Human Prostate Cancer Cells in Vivo, whereas Stat5b Has a Preferential Role in the Promotion of Prostate Cancer Cell Viability and Tumor Growth
- (2010) Lei Gu et al. AMERICAN JOURNAL OF PATHOLOGY
- Concise Total Synthesis of Sintokamides A, B, and E by a Unified, Protecting-Group-Free Strategy
- (2010) Zhenhua Gu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oxidative phosphorylation in cancer cells
- (2010) Giancarlo Solaini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species
- (2010) Y. Jin et al. CANCER RESEARCH
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
- (2010) Lei Gu et al. ENDOCRINE-RELATED CANCER
- The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells
- (2010) Patrice E. Moss et al. EXPERIMENTAL CELL RESEARCH
- Suppression of the androgen receptor function by quercetin through protein–protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells
- (2010) Huiqing Yuan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
- (2010) Pinar Uysal-Onganer et al. Molecular Cancer
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
- (2010) Xiaomei Ren et al. ACS Medicinal Chemistry Letters
- Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer
- (2009) L. Gan et al. CANCER RESEARCH
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
- (2009) J. Y. Chun et al. CLINICAL CANCER RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Minireview: Not Picking Pockets: Nuclear Receptor Alternate-Site Modulators (NRAMs)
- (2009) Terry W. Moore et al. MOLECULAR ENDOCRINOLOGY
- Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
- (2009) Aruna D. Balgi et al. PLoS One
- Non-competitive androgen receptor inhibition in vitro and in vivo
- (2009) J. O. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Stat3 Promotes Metastatic Progression of Prostate Cancer
- (2008) Junaid Abdulghani et al. AMERICAN JOURNAL OF PATHOLOGY
- Sintokamides A to E, Chlorinated Peptides from the SpongeDysideasp. that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
- (2008) Marianne D. Sadar et al. ORGANIC LETTERS
- Live-cell analysis of mitotic spindle formation in taxol-treated cells
- (2008) Jessica E. Hornick et al. CELL MOTILITY AND THE CYTOSKELETON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now